Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 25.03.2026 FGOV LN IE00BKS2X200 58,638.00 GBP 867,190.95 17.092  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 25.03.2026 IPXE.IM IE00BFD26097 50,002.00 EUR 1,151,060.66 23.020  ...
-

PackEdge Expands into Commercial Printing with Acquisition of Keno Graphics

HAMDEN, Conn.--(BUSINESS WIRE)--PackEdge acquires Keno Graphics, combining packaging and print to deliver faster, more seamless solutions for clients....
-

Wiley Announces Quarterly Dividend; Allocated $126 million to Dividends and Repurchases in 9 Months of Fiscal 2026

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that its Board of Directors has declared a quarterly cash dividend of $0.355 per share on its Class A and Class B Common Stock, payable on April 23, 2026, to shareholders of record on April 7, 2026. The quarterly dividend is equivalent to an annual dividend of $1.42 per share, an increase from...
-

NMG and Government of Canada Execute Updated Binding Offtake and Marketing Framework for Matawinie Graphite

MONTRÉAL--(BUSINESS WIRE)--Nouveau Monde Graphite Inc. (“NMG” or the “Company”) (NYSE: NMG, TSX: NOU) has executed an updated binding long-form term sheet with the Government of Canada, represented by Public Services and Procurement Canada (“PSPC”), setting out the principal commercial terms for the supply, storage and resale of graphite concentrate from the Company’s Phase‑2 Matawinie Mine in Québec, Canada. Eric Desaulniers, Founder, President, and CEO of NMG, stated: “This updated framework...
-

Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ATRA

LOS ANGELES--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – ATRA...
-

NEUPATH HEALTH REPORTS FOURTH QUARTER AND YEAR-END 2025 RESULTS

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services markets, today announced its financial and operating results for the three months and year ended December 31, 2025, the grant of stock options (“Options”) and restricted share unit...
-

Hercules Capital, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – HTGC

LOS ANGELES--(BUSINESS WIRE)--Hercules Capital, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – HTGC...
-

NMG et le gouvernement du Canada signent une entente contraignante d’achat « offtake » et de mise en marché pour le graphite de la mine Matawinie

MONTRÉAL--(BUSINESS WIRE)--Nouveau Monde Graphite Inc. (« NMG » ou la « Société ») (NYSE : NMG, TSX : NOU) a convenu avec le gouvernement du Canada, représenté par Services publics et Approvisionnement Canada (« SPAC »), une lettre d’intention détaillée contraignante actualisée énonçant les principales conditions commerciales relatives à l’approvisionnement, au stockage et à la revente de concentré de graphite provenant de la mine Matawinie de la phase 2 au Québec (Canada). Eric Desaulniers, fo...
-

ImmunityBio Confirms Statistical Power in Pivotal Randomized BCG-Naïve NMIBC Trial to Detect Clinically Meaningful Differences Between ANKTIVA® Plus BCG Versus BCG Alone; Supplemental BLA Submission on Track for 2026

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a vertically integrated, commercial-stage immunotherapy company, today announced that based on the Independent Data Monitoring Committee (IDMC) review of the interim data, the committee recommended that the study is adequately powered to detect the pre-specified clinically meaningful difference in complete response (CR) rate between the experimental arm (ANKTIVA + BCG) and the control arm (BCG alone) at the protocol-specifi...